Investing In Capacity – API Commercial Manufacturing
![iStock-188078261-lab-pharma-development-equipment iStock-188078261-lab-pharma-development-equipment](https://vertassets.blob.core.windows.net/image/0dab6f1f/0dab6f1f-f169-4197-951c-a100c3d5bdc0/375_250-istock_188078261_lab_pharma_development.jpg)
Cambrex was approached by a top 10 Asian pharmaceutical company looking to partner with a contract manufacturing organization (CMO) with commercial manufacturing capabilities and expertise, mid- to large-scale cGMP assets and exemplary quality systems and US FDA track record. The requirement was to find a cost effective process to produce the API for a new drug.
Cambrex had previously been working with the emerging company which initially developed the drug, so proactively approached the customer with innovative ideas for a new cost effective method. The original chemistry included a high number of chemical and purification steps and Cambrex believed a more efficient method was achievable. The customer felt that Cambrex had the necessary know-how, scale-up and commercial production expertise to meet its requirements.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.